- Retraction Note
- Open Access
- Published:
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
BMC Research Notes volume 7, Article number: 868 (2014)
- The original article was published in BMC Research Notes 2014 7:52
Retraction
This article [1] has been retracted by the editors of BMC Research Notes because, contrary to the statement in the manuscript, Moi University Institutional Research and Ethics Committee (IREC) has confirmed that ethics approval was not obtained to conduct this study. In addition, the authors did not have permission to use data from the DREAM program.
References
- 1.
Ngemu EK, Khayeka–Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E: Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women. BMC Res Notes. 2014, 7: 52-10.1186/1756-0500-7-52.
Author information
Affiliations
Corresponding author
Additional information
The online version of the original article can be found at 10.1186/1756-0500-7-52
Rights and permissions
About this article
Cite this article
Ngemu, E.K., Khayeka–Wandabwa, C., Kweka, E.J. et al. Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women. BMC Res Notes 7, 868 (2014). https://doi.org/10.1186/1756-0500-7-868
Received:
Accepted:
Published: